Topical dermatological products
Executive Summary
The draft guidance for bioequivalence of topical dermatological dosage forms will be the topic of discussion at an Oct. 23 joint meeting of FDA's Dermatologic & Ophthalmic Drugs Advisory Committee and the Pharmaceutical Science Advisory Committee